Medtronic is a medical technology company, offering innovative therapies to fulfill its mission of alleviating pain, restoring health and extending life. The Company has six main business units, which develop and manufacture devices and therapies to treat more than 30 chronic diseases, including heart failure, Parkinson's disease, urinary incontinence, Down's syndrome, obesity, chronic pain, spinal disorders and diabetes.

Type
Public
HQ
Minneapolis, US
Founded
1949
Size (employees)
88,000 (est)
Medtronic was founded in 1949 and is headquartered in Minneapolis, US
Report incorrect company information

Key People/Management at Medtronic

Omar Ishrak

Omar Ishrak

Chairman and CEO
Richard E. Kuntz

Richard E. Kuntz

Senior Vice President and Chief Scientific, Clinical and Regulatory Officer
Carol Surface

Carol Surface

SVP and Chief Human Resources Officer

Medtronic Office Locations

Medtronic has offices in Portsmouth, Plymouth, Hyderabad, Augusta and in 47 other locations
Minneapolis, US (HQ)
710 Medtronic Parkway
Miami, US
Doral Corporate Centre II, 3750 NW 87th Avenue, Suite 700
Plymouth, US
3800 Annapolis Ln N #175
Portsmouth, US
180 International Dr
San Antonio, US
18302 Talavera Ridge
Sunnyvale, US
540 Oakmead Pkwy
Show all (52)
Report incorrect company information

Medtronic Financials and Metrics

Medtronic Financials

Medtronic's revenue was reported to be $29.71 b in FY, 2017 which is a 3% increase from the previous period.
USD

Revenue (Q3, 2018)

21.8 b

Gross profit (Q3, 2018)

15.1 b

Gross profit margin (Q3, 2018), %

69.5%

Net income (Q3, 2018)

1.6 b

EBIT (Q3, 2018)

4.7 b

Market capitalization (21-May-2018)

115.6 b

Closing share price (21-May-2018)

85.3

Cash (26-Jan-2018)

6.4 b

EV

135.2 b
Medtronic's current market capitalization is $115.6 b.
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017

Revenue

17 b20.3 b28.8 b29.7 b

Revenue growth, %

19%42%3%

Cost of goods sold

4.3 b6.3 b9.1 b9.3 b

Gross profit

12.7 b14 b19.7 b20.4 b
Quarterly
USDQ3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

7.3 b7.1 b6.9 b7.2 b7.3 b7.28 t7.4 b7.05 t21.8 b

Cost of goods sold

2.5 b2.2 b2.1 b2.3 b2.3 b2.27 t2.3 b2.12 t6.7 b

Gross profit

4.8 b4.9 b4.8 b4.9 b5 b5.01 t5 b4.93 t15.1 b

Gross profit Margin, %

66%69%69%68%68%69%68%70%69%
Annual
usdY, 2014FY, 2015FY, 2016FY, 2017

Cash

13.2 m4.8 b186.4 m5 b

Accounts Receivable

17.1 m

Inventories

1.7 b3.5 b3.5 b3.3 b

Current Assets

21.2 b30.8 b23.6 b24.9 b
Quarterly
USDQ3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

46 k3 b2.4 b2.7 b3.1 b3 b2.8 b4.7 b5.5 b6.4 b

Accounts Receivable

(68 m)

Inventories

3.4 b3.5 b3.5 b3.6 b3.7 b3.7 b3.5 b3.8 b

Current Assets

46 k29.1 b28.7 b27.6 b23.5 b22.5 b22.4 b24.8 b25.2 b26.6 b
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017

Net Income

3.1 b2.7 b3.5 b4 b

Depreciation and Amortization

349 m1.3 b2.8 b2 b

Inventories

(39 m)(282 m)(186 m)

Accounts Payable

(16.7 m)
Quarterly
USDQ3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q3, 2018

Net Income

(37.1 m)820 m1.3 b2.4 b929 m2 b2.9 b1 b1.6 b

Depreciation and Amortization

701 m1.4 b2.1 b737 m1.5 b2.2 b636 m2 b

Inventories

(207 m)(326 m)(388 m)(101 m)(187 m)(261 m)(318 m)

Accounts Payable

1.3 b1.4 b1.4 b13 m
USDY, 2018

EV/EBIT

28.7 x

EV/CFO

37.1 x

Financial Leverage

1.9 x
Show all financial metrics

Medtronic Operating Metrics

Medtronic's Patients was reported to be 65 m in FY, 2016.
FY, 2014FY, 2015FY, 2016

Countries

160 160

Patents Issued

27 k53 k45 k

Patients

65 m
Show all operating metrics

Medtronic Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
Visionsense Ltd April 11, 2018$75 m
Report incorrect company information

Medtronic News and Updates

Menstrual Cup Market to grow at a CAGR of 3.97% including key players Boston Scientific, Medtronic, Sorin, St. Jude Medical

HTF analysts forecast the global menstrual cups market to grow at a CAGR of 3.97% during the period 2017-2021. Posted via Industry Today. Follow us on Twitter @IndustryToday

Muscle Relaxant Drugs 2018 Global Market Key Players - Medtronic Neuromodulation (Medtronic), Vertical Pharmaceuticals LLC, Par Sterile Products, Johnson & Johnson, Abbott Laboratories -Analysis And Forecast To 2023

Wiseguyreports.Com Adds “Muscle Relaxant Drugs – Global Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2023” To Its Research Database. Posted via Industry Today. Follow us on Twitter @IndustryToday

Automated Insulin Delivery Systems Market to Record an Exponential CAGR by 2025

Automated Insulin Delivery Systems Market: Global Industry Trend Analysis 2012 to 2017 and Forecast 2017 - 2025 Posted via Industry Today. Follow us on Twitter @IndustryToday

Gauze Bandage Rolls Market : Recent Industry Trends, Analysis and Forecast 2018 - 2028

Future Market Insights has announced the addition of the “Gauze Bandage Rolls Market: Global Industry Analysis and Opportunity Assessment, 2018 - 2028"report to their offering. Posted via Industry Today. Follow us on Twitter @IndustryToday

Anesthesia and Respiratory Devices Market - Changing Lifestyle, Innovation and developments in Technology Drives Demand

OrbisResearch.com Publish New Market Research Report on -“Global Anesthesia and Respiratory Devices Market 2018-2022.” Posted via Industry Today. Follow us on Twitter @IndustryToday

Neuromodulation Devices Market Share 2018; Increasing Prevalence of Neurological Disorders like Alzheimer’s And Parkinson’s Diseases | Illustrious Growth Seen in Healthcare Industry – Asserts MRFR

Neuromodulation Devices Market Report Split Into Several Key Regions, With Sales, Revenue, And Market Share And Growth Rate, Covering North America, Europe, Asia Pacific, Middle East And Africa. And It Is Incorporated On Marketresearchfuture.Com With 115 Pages. Neuromodulation Devices Market Sector …
Show more
Report incorrect company information